Tokyo - Delayed Quote JPY

Paltac Corporation (8283.T)

4,082.00
+30.00
+(0.74%)
At close: 3:30:00 PM GMT+9
Loading Chart for 8283.T
  • Previous Close 4,052.00
  • Open 4,054.00
  • Bid 4,069.00 x --
  • Ask 4,090.00 x --
  • Day's Range 4,054.00 - 4,116.00
  • 52 Week Range 3,449.00 - 4,633.00
  • Volume 68,300
  • Avg. Volume 96,931
  • Market Cap (intraday) 251.762B
  • Beta (5Y Monthly) -0.13
  • PE Ratio (TTM) 11.14
  • EPS (TTM) 366.30
  • Earnings Date Jul 28, 2025 - Aug 1, 2025
  • Forward Dividend & Yield 126.00 (3.11%)
  • Ex-Dividend Date Sep 29, 2025
  • 1y Target Est 5,157.50

Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. The company was founded in 1898 and is headquartered in Osaka, Japan. Paltac Corporation is a subsidiary of MediPal Holdings Corporation.

www.paltac.co.jp

1,478

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 8283.T

View More

Performance Overview: 8283.T

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

8283.T
5.17%
Nikkei 225 (^N225)
6.01%

1-Year Return

8283.T
1.27%
Nikkei 225 (^N225)
3.32%

3-Year Return

8283.T
1.90%
Nikkei 225 (^N225)
42.02%

5-Year Return

8283.T
11.90%
Nikkei 225 (^N225)
83.52%

Compare To: 8283.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8283.T

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    249.91B

  • Enterprise Value

    180.34B

  • Trailing P/E

    11.06

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.21

  • Price/Book (mrq)

    0.87

  • Enterprise Value/Revenue

    0.15

  • Enterprise Value/EBITDA

    4.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.18%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    737.13B

  • Net Income Avi to Common (ttm)

    8.67B

  • Diluted EPS (ttm)

    366.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.25B

  • Total Debt/Equity (mrq)

    67.18%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8283.T

View More

Company Insights: 8283.T

Research Reports: 8283.T

View More

People Also Watch